Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -77.95%6.82M | 1,517.76%18.77M | 819.33%4.38M | 208.55%45.07M | 18.46%12.5M | 49,995.16%30.94M | -58.56%1.16M | -63.91%476K | -44.51%14.61M | 85.10%10.55M |
| Cost of revenue | 200.23%33.53M | -40.03%11.17M | ||||||||
| Gross profit | 235.59%11.54M | -55.34%3.44M | ||||||||
| Operating expense | -74.07%6.15M | 555.84%14.99M | 166.03%4.04M | 18.40%5.43M | 12.21%12.51M | 4,832.85%23.73M | -22.17%2.29M | 27.65%1.52M | -33.02%4.58M | 183.73%11.15M |
| Other operating expenses | -73.21%6.5M | 558.18%16.34M | 156.44%4.56M | 3.19%6.63M | 6.04%12.7M | 1,990.00%24.24M | -21.23%2.48M | 36.95%1.78M | -14.99%6.42M | 191.82%11.98M |
| Total other operating income | -33.66%343K | 585.28%1.35M | 100.38%521K | -34.73%1.2M | -77.05%190K | -23.86%517K | -8.37%197K | 138.53%260K | 158.32%1.84M | 205.57%828K |
| Operating profit | -90.72%669K | 436.00%3.78M | 132.12%335K | 632.88%6.11M | 97.99%-12K | 1,427.44%7.21M | -721.17%-1.13M | -908.53%-1.04M | -234.31%-1.15M | -253.90%-598K |
| Net non-operating interest income (expenses) | -70.83%-164K | -167.57%-198K | -775.00%-140K | -42.09%-216.32K | -172.73%-30K | -357.14%-96K | -39.62%-74K | 76.12%-16K | -160.23%-152.24K | 51.11%-11K |
| Non-operating interest expense | 70.83%164K | 167.57%198K | 775.00%140K | 42.09%216.32K | 172.73%30K | 357.14%96K | 39.62%74K | -76.12%16K | 160.23%152.24K | -51.11%11K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -1M | 0 | ||||||||
| Less:Write off | ---- | ---- | ---- | --1M | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -92.90%505K | 398.75%3.58M | 118.41%195K | 476.75%4.89M | 93.10%-42K | 1,360.99%7.11M | -531.05%-1.2M | -1,808.06%-1.06M | -263.34%-1.3M | -266.37%-609K |
| Income tax | -61.16%524K | 3,372.55%1.77M | 107.69%162K | 93.40%1.32M | -38.10%39K | 953.91%1.35M | -56.78%51K | -80.50%78K | 0.11%680.51K | -32.10%63K |
| Net income | -100.33%-19K | 244.88%1.81M | 102.90%33K | 280.71%3.58M | 87.95%-81K | 932.80%5.76M | -305.84%-1.25M | -236.39%-1.14M | -1,816.92%-1.98M | -345.91%-672K |
| Net income continuous operations | -100.33%-19K | 244.88%1.81M | 102.90%33K | 280.71%3.58M | 87.95%-81K | 932.80%5.76M | -305.84%-1.25M | -236.39%-1.14M | -1,816.92%-1.98M | -345.91%-672K |
| Noncontrolling interests | -115.87%-449K | 84.62%-26K | -154.90%-390K | -30.55%-716.88K | -72.11%-253K | -388.89%-208K | 29.88%-169K | 34.62%-153K | -45.41%-549.12K | -77.89%-147K |
| Net income attributable to the company | -92.80%430K | 270.77%1.85M | 142.99%423K | 400.23%4.29M | 132.76%172K | 881.54%5.97M | -1,513.43%-1.08M | -846.15%-984K | -390.12%-1.43M | -247.51%-525K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -92.80%430K | 270.77%1.85M | 142.99%423K | 400.23%4.29M | 132.76%172K | 881.54%5.97M | -1,513.43%-1.08M | -846.15%-984K | -390.12%-1.43M | -247.51%-525K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -93.35%0.0035 | 249.07%0.0161 | 141.38%0.0036 | 398.44%0.0382 | 130.00%0.0015 | 52,700.00%0.0526 | -2,060.00%-0.0108 | -866.67%-0.0087 | -390.91%-0.0128 | -256.25%-0.005 |
| Diluted earnings per share | -93.35%0.0035 | 249.07%0.0161 | 141.38%0.0036 | 398.44%0.0382 | 130.00%0.0015 | 52,700.00%0.0526 | -2,060.00%-0.0108 | -866.67%-0.0087 | -397.67%-0.0128 | -261.29%-0.005 |
| Dividend per share | 0 | 0 | 0 | 25.00%0.025 | 25.00%0.025 | 0 | 0 | 0 | 0.00%0.02 | 0.00%0.02 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.